{
  "abstract": "Background: Cerebral embolic protection (CEP) devices have been developed to reduce postoperative neurological outcomes after transcatheter aortic valve implantation (TAVI); however, their effectiveness remains controversial.\n\nObjective: To evaluate the impact of CEP use during TAVI on the occurrence in clinical outcomes.\n\nMethods: Databases were used to search for randomized clinical trials. The occurrence of all strokes, of disabling strokes specifically, transient ischemic attacks (TIAs), all-cause mortality, and vascular complications were analyzed. Conventional meta-analysis was conducted using fixed-effects modeling and trial sequential analysis (TSA: type I error of 5%, power of 90%). The systematic review protocol was registered on the International Prospective Register of Systematic Reviews (PROSPERO; CRD420251081075).\n\nResults: In total, eight clinical trials were included, gathering 11,589 patients randomized between those who used the devices (5,943) and those who did not (5,646). The meta-analysis demonstrated no significant association between CEP use and reduced odds of all-cause stroke (OR = 0.92, 95% CI: 0.73–1.15, p = 0.46) and disabling stroke (OR = 0.80, 95% CI: 0.57–1.13, p = 0.20). The sequential analysis identified a lack of evidence for all strokes (required sample size [rSS] = 38,626; 10.53%), disabling strokes (rSS = 59,732; 17.05%). In terms of mortality, there was no significance in the use of devices (OR = 1.09, 95% CI: 0.71–1.69, p = 0.69), reaching evidence for support (rSS = 7,053; 42.25%);\n\nConclusion: The data on the use of CEP is insufficient to support meta-analytic conclusions regarding cerebrovascular outcomes. Nevertheless, TSA demonstrated evidence supporting futility regarding mortality reduction.",
  "abstract_shown": true,
  "affiliations": [
    "Universidade Federal do Piauí, Faculdade de Medicina Teresina PI Brazil",
    "Universidade Federal do Piauí, Faculdade de Medicina, Hospital Universitário Teresina PI Brazil"
  ],
  "article_type": "research article",
  "arxiv": null,
  "author_total": 7,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Aldo José Silva de Castro Costa",
      "orcid": "0009-0001-5149-4958"
    },
    {
      "affs": [
        0
      ],
      "name": "Marcus Vinícius Costa Fernandes",
      "orcid": "0000-0002-7769-742X"
    },
    {
      "affs": [
        0
      ],
      "name": "Thaynar Cavalcante Batista",
      "orcid": "0009-0007-3122-0929"
    },
    {
      "affs": [
        0
      ],
      "name": "Ana Virgínia de Jesus Félix",
      "orcid": "0009-0005-1587-6237"
    },
    {
      "affs": [
        0
      ],
      "name": "Tamara Larissa Silva Barbosa",
      "orcid": "0009-0000-3816-3006"
    },
    {
      "affs": [
        0
      ],
      "name": "Isis Maria Lima Cruz",
      "orcid": "0009-0009-5004-0397"
    },
    {
      "affs": [
        1
      ],
      "name": "Gustavo Sousa Noleto",
      "orcid": "0000-0002-1907-3774"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/ftbm6qd53thr0.bib",
  "cited_by": 0,
  "doi": "10.1055/s-0046-1829157",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13743267/",
  "id": "ftbm6qd53thr0",
  "issns": [
    "0004-282X",
    "1678-4227"
  ],
  "landing_url": "https://doi.org/10.1055/s-0046-1829157",
  "language": "en",
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Original Article"
    ],
    [
      "openalex",
      "2705|Cardiac Valve Diseases and Treatments"
    ]
  ],
  "openalex": "W7225414463",
  "pdf_url": null,
  "pmcid": "PMC13743267",
  "pmid": "42994438",
  "published": "2026-11-06",
  "publisher": "Academia Brasileira de Neurologia",
  "ris": "https://research.draconitic.com/paper/ftbm6qd53thr0.ris",
  "sources": [
    {
      "first_seen": "2026-11-10T12:23:57Z",
      "native_id": "PMC13743267",
      "source": "pmc",
      "url": "https://doi.org/10.1055/s-0046-1829157"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2705|Cardiac Valve Diseases and Treatments",
      "subfield": "cardiovascular"
    }
  ],
  "title": "Safety and efficacy of cerebral embolic protection devices during TAVI: a meta-analysis and sequence analysis of trials",
  "title_text": "Safety and efficacy of cerebral embolic protection devices during TAVI: a meta-analysis and sequence analysis of trials",
  "type": "peer-reviewed",
  "updated_at": "2026-11-10T12:23:57Z",
  "url": "https://research.draconitic.com/paper/ftbm6qd53thr0",
  "venue": "Arquivos de Neuro-Psiquiatria",
  "versions": []
}